ArticleFrontiers in pharmacology2020

CCT020312 Inhibits Triple-Negative Breast Cancer Through PERK Pathway-Mediated G1 Phase Cell Cycle Arrest and Apoptosis.

Xiaoli Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.